Drug | Action | Mechanism Category | Class of Immunosuppressant | Possible Side Effects | Distinguishing Factor of Side Effect | Possible Use Cases | Additional Information for Step 1 |
---|---|---|---|---|---|---|---|
Glucocorticoids | Regulate gene expression | Gene Regulation | Steroid | Weight gain, osteoporosis | Osteoporosis | Asthma, autoimmune diseases | Cushing's syndrome risk |
Cyclosporine | Inhibits calcineurin phosphatase activity | Enzyme Inhibition | Calcineurin Inhibitor | Kidney dysfunction, hypertension | Kidney dysfunction | Organ transplantation | Gingival hyperplasia |
Tacrolimus | Inhibits calcineurin phosphatase activity | Enzyme Inhibition | Calcineurin Inhibitor | Kidney dysfunction, diabetes | Diabetes | Organ transplantation | Less nephrotoxic than Cyclosporine |
Sirolimus | Inhibits mTOR kinase activity; blocks T cell proliferation | Enzyme Inhibition | mTOR Inhibitor | Hyperlipidemia, anemia | Hyperlipidemia | Kidney transplantation | Not nephrotoxic |
Azathioprine | Inhibits DNA synthesis | DNA Synthesis Inhibition | Antimetabolite | Bone marrow suppression, liver toxicity | Liver toxicity | Rheumatoid arthritis | Prodrug of 6-mercaptopurine |
Methotrexate | Inhibits AICAR transformylase; anti-inflammatory | Enzyme Inhibition | Antimetabolite | Liver toxicity, folic acid deficiency | Folic acid deficiency | Cancer, rheumatoid arthritis | Folinic acid as rescue therapy |
Mycophenolate mofetil | Inhibits Inosine monophosphate dehydrogenase | Enzyme Inhibition | Antimetabolite | Diarrhea, leukopenia | Leukopenia | Organ transplantation | Selective for lymphocytes |
Leflunomide | Inhibits dihydroorotate dehydrogenase | Enzyme Inhibition | Pyrimidine Synthesis Inhibitor | Liver toxicity, hypertension | Hypertension | Rheumatoid arthritis | Teratogenic |
Cyclophosphamide | Alkylates DNA | DNA Alkylation | Alkylating Agent | Bone marrow suppression, bladder toxicity | Bladder toxicity | Cancer, lupus | Hemorrhagic cystitis risk |
Infliximab | Binds to TNF-a preventing its action | Cytokine Inhibition | TNF-alpha Inhibitor | Infections, infusion reactions | Infusion reactions | Crohn's disease, rheumatoid arthritis | Chimeric antibody |
Adalimumab | Binds to TNF-a preventing its action | Cytokine Inhibition | TNF-alpha Inhibitor | Infections, injection site reactions | Injection site reactions | Rheumatoid arthritis, psoriasis | Fully human antibody |
Etanercept | Binds to TNF-a preventing its action | Cytokine Inhibition | TNF-alpha Inhibitor | Infections, injection site reactions | Injection site reactions | Rheumatoid arthritis, psoriasis | Fusion protein |
Omalizumab | Binds to IgE preventing its action | Immunoglobulin Inhibition | IgE Inhibitor | Anaphylaxis, injection site reactions | Anaphylaxis | Asthma, chronic urticaria | Monoclonal antibody |
Tofacitinib | Inhibits JAK enzymes | Enzyme Inhibition | JAK Inhibitor | Infections, elevated liver enzymes | Elevated liver enzymes | Rheumatoid arthritis, psoriatic arthritis | Oral administration |
Rituximab | Binds to CD20. Causes depletion of circulating B cells | Cell Depletion | CD20 Monoclonal Antibody | Infusion reactions, infections | Infusion reactions | Non-Hodgkin lymphoma, rheumatoid arthritis | Chimeric antibody |
Tocilizumab | Antagonists at IL-6 receptors | Cytokine Inhibition | IL-6 Inhibitor | Elevated liver enzymes, infections | Elevated liver enzymes | Rheumatoid arthritis, giant cell arteritis | Monoclonal antibody |
Sarilumab | Antagonists at IL-6 receptors | Cytokine Inhibition | IL-6 Inhibitor | Elevated liver enzymes, infections | Elevated liver enzymes | Rheumatoid arthritis | Monoclonal antibody |
Abatacept | Interferes with T-cell activation | T-cell Modulation | CTLA-4 Inhibitor | Infections, headache | Headache | Rheumatoid arthritis, juvenile idiopathic arthritis | Fusion protein |
Drug | Action | Mechanism Category | Class of Immunosuppressant | Possible Side Effects | Distinguishing Factor of Side Effect | Possible Use Cases | Additional Information for Step 1 |
---|---|---|---|---|---|---|---|
Glucocorticoids | Regulate gene expression | Gene Regulation | Steroid | Weight gain, osteoporosis | Osteoporosis | Asthma, autoimmune diseases | Cushing's syndrome risk |
Cyclosporine | Inhibits calcineurin phosphatase activity | Enzyme Inhibition | Calcineurin Inhibitor | Kidney dysfunction, hypertension | Kidney dysfunction | Organ transplantation | Gingival hyperplasia |
Tacrolimus | Inhibits calcineurin phosphatase activity | Enzyme Inhibition | Calcineurin Inhibitor | Kidney dysfunction, diabetes | Diabetes | Organ transplantation | Less nephrotoxic than Cyclosporine |
Sirolimus | Inhibits mTOR kinase activity; blocks T cell proliferation | Enzyme Inhibition | mTOR Inhibitor | Hyperlipidemia, anemia | Hyperlipidemia | Kidney transplantation | Not nephrotoxic |
Azathioprine | Inhibits DNA synthesis | DNA Synthesis Inhibition | Antimetabolite | Bone marrow suppression, liver toxicity | Liver toxicity | Rheumatoid arthritis | Prodrug of 6-mercaptopurine |
Methotrexate | Inhibits AICAR transformylase; anti-inflammatory | Enzyme Inhibition | Antimetabolite | Liver toxicity, folic acid deficiency | Folic acid deficiency | Cancer, rheumatoid arthritis | Folinic acid as rescue therapy |
Mycophenolate mofetil | Inhibits Inosine monophosphate dehydrogenase | Enzyme Inhibition | Antimetabolite | Diarrhea, leukopenia | Leukopenia | Organ transplantation | Selective for lymphocytes |
Leflunomide | Inhibits dihydroorotate dehydrogenase | Enzyme Inhibition | Pyrimidine Synthesis Inhibitor | Liver toxicity, hypertension | Hypertension | Rheumatoid arthritis | Teratogenic |
Cyclophosphamide | Alkylates DNA | DNA Alkylation | Alkylating Agent | Bone marrow suppression, bladder toxicity | Bladder toxicity | Cancer, lupus | Hemorrhagic cystitis risk |
Infliximab | Binds to TNF-a preventing its action | Cytokine Inhibition | TNF-alpha Inhibitor | Infections, infusion reactions | Infusion reactions | Crohn's disease, rheumatoid arthritis | Chimeric antibody |
Adalimumab | Binds to TNF-a preventing its action | Cytokine Inhibition | TNF-alpha Inhibitor | Infections, injection site reactions | Injection site reactions | Rheumatoid arthritis, psoriasis | Fully human antibody |
Etanercept | Binds to TNF-a preventing its action | Cytokine Inhibition | TNF-alpha Inhibitor | Infections, injection site reactions | Injection site reactions | Rheumatoid arthritis, psoriasis | Fusion protein |
Omalizumab | Binds to IgE preventing its action | Immunoglobulin Inhibition | IgE Inhibitor | Anaphylaxis, injection site reactions | Anaphylaxis | Asthma, chronic urticaria | Monoclonal antibody |
Tofacitinib | Inhibits JAK enzymes | Enzyme Inhibition | JAK Inhibitor | Infections, elevated liver enzymes | Elevated liver enzymes | Rheumatoid arthritis, psoriatic arthritis | Oral administration |
Rituximab | Binds to CD20. Causes depletion of circulating B cells | Cell Depletion | CD20 Monoclonal Antibody | Infusion reactions, infections | Infusion reactions | Non-Hodgkin lymphoma, rheumatoid arthritis | Chimeric antibody |
Tocilizumab | Antagonists at IL-6 receptors | Cytokine Inhibition | IL-6 Inhibitor | Elevated liver enzymes, infections | Elevated liver enzymes | Rheumatoid arthritis, giant cell arteritis | Monoclonal antibody |
Sarilumab | Antagonists at IL-6 receptors | Cytokine Inhibition | IL-6 Inhibitor | Elevated liver enzymes, infections | Elevated liver enzymes | Rheumatoid arthritis | Monoclonal antibody |
Abatacept | Interferes with T-cell activation | T-cell Modulation | CTLA-4 Inhibitor | Infections, headache | Headache | Rheumatoid arthritis, juvenile idiopathic arthritis | Fusion protein |
Hmmm, hirsutism for cyclosporin? Thank you for the post!
This is a great! thanks for posting it
Thank you
Thank you